Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
0,00%
NASDAQ Composite
15.657,82
0,00%
Bitcoin
57.738,40
-4,72%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Windtree Therapeutics Inc (WINT) Windtree Therapeutics Inc (WINT) Notizie

Windtree Therapeutics Inc

WINT
4,96
-0,105 (-2,07%)
Pre Mercato
Ultimo aggiornamento: 14:50:52
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/4/202414:00GLOBEWindtree Therapeutics Announces Reverse Stock Split
17/4/202414:00GLOBEWindtree Therapeutics Reports Fourth Quarter and Year-End..
08/4/202422:48GLOBEWindtree Acquires Early-Stage, Novel Oncology Platform and..
16/2/202423:07EDGAR2Form 8-K - Current report
14/2/202423:23EDGAR2Form S-3 - Registration statement under Securities Act of..
14/2/202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:40EDGAR2Form PRE 14A - Other preliminary proxy statements
01/2/202423:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202414:00GLOBEWindtree Renews Agreement with Chang Gung University for..
31/1/202414:40IHNWWindtree Therapeutics Announces Engagement of Strategic..
31/1/202414:00EDGAR2Form 8-K - Current report
31/1/202414:00GLOBEWindtree Therapeutics Announces Engagement of Strategic..
25/1/202415:04IHNWWindtree Eliminates $15 Million Contingent Liability to..
25/1/202414:34EDGAR2Form 8-K - Current report
25/1/202414:30GLOBEWindtree Eliminates $15 Million Contingent Liability to..
22/1/202422:45EDGAR2Form 8-K - Current report
17/1/202414:00GLOBEWindtree Therapeutics Announces License Agreement with Lee’s..
17/1/202413:56EDGAR2Form 8-K - Current report
16/1/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/1/202422:05GLOBEWindtree Therapeutics Announces Reduction In Arrythmias In A..
18/12/202314:00GLOBEWindtree Therapeutics Announces the Start of Patient Dosing..
16/11/202314:00GLOBEWindtree Therapeutics Announces Issuance of New Pure SERCA2a..
13/11/202317:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/11/202322:21EDGAR2Form 8-K - Current report
09/11/202322:15GLOBEWindtree Therapeutics Reports Third Quarter 2023 Financial..
09/11/202322:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202314:00GLOBEWindtree to Present at the Sidoti Micro Cap Conference on..
12/10/202313:30GLOBEWindtree to Present at the ThinkEquity Conference on October..
10/10/202313:30GLOBEWindtree to Participate in the Lytham Partners Fall 2023..
03/10/202314:00GLOBEWindtree to Present at the Dawson James Small Cap Growth..
28/9/202313:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202313:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202314:48EDGAR2Form 8-K - Current report
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
06/9/202301:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/8/202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/8/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202322:15EDGAR2Form 8-K - Current report
26/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202314:00GLOBEWindtree Announces Issuance of Composition of Matter Patent..
16/8/202323:19EDGAR2Form 8-K - Current report
07/8/202322:05GLOBEWindtree Therapeutics Reports Second Quarter 2023 Financial..
07/8/202322:02EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 5,065

La tua Cronologia

NASDAQ
WINT
Windtree Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network